HIV/AIDS Clinical Trials Network Clinical Trials Units (UM1 Clinical Trial Required)
Open Posted
- Opportunity number
- RFA-AI-28-004
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
-
- 93.DE1 Oral Diseases and Disorders Research -Research Projects
- 93.HDR Child Health and Human Development Extramural Research Projects
- 93.HL2 National Heart, Lung, and Blood Institute - Research Projects
- 93.DA1 Drug Use and Addiction Research Programs - Research Projects
- 93.8RP National Institute of Allergy and Infectious Diseases- Research Projects
- 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
- 93.242 Mental Health Research Grants
- 93.KRP Diabetes, Digestive, Kidney Extramural Research - Research Projects
- 93.AGR National Institute on Aging Research Projects
- 93.310 Trans-NIH Research Support
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- City/Township Governments
- Other
- Higher Education Inst. (Public)
- State Governments
- Special District Governments
- Independent School Districts
- 501(c)(3) Nonprofits
- Tribal Organizations (Not Federally Recognized)
- Higher Education Inst. (Private)
- Public or Indian Housing Auth.
- Small Businesses
- Non-501(c)(3) Nonprofits
- County Governments
- Tribal Governments (Federally Recognized)
- For Profit Organizations
- Points of contact
Opportunity details come from Grants.gov. Updated .
About this opportunity
NIAID, part of the National Institutes of Health within HHS, is soliciting cooperative agreement applications under the UM1 mechanism to establish HIV/AIDS Clinical Trials Network Clinical Trials Units (CTUs), with applications due March 9, 2027 per the listing. Awards are not budget-capped, and NIAID will commit an estimated $60 million across 45-65 awards in FY2028. The revised full announcement supersedes the original RFA-AI-28-004, which set a March 10, 2027 due date. The revision requires submission by 5:00 PM local time on the posted application due date, with an open date of February 9, 2027 and an earliest start date of March 9, 2027.
Eligible applicants include higher education institutions, nonprofits with and without 501(c)(3) status, for-profit organizations, small businesses, state, county, city or township, and special district governments, independent school districts, public housing authorities, federally recognized and other tribal governments, faith-based or community-based organizations, regional organizations, and federal agencies. Foreign institutions may apply, but NIH will not issue awards involving foreign subawards or subcontracts. Applicants must register in SAM, obtain a Unique Entity Identifier, complete eRA Commons registration, and register with Grants.gov. The listing specifies no cost share or matching requirement.
Each CTU comprises an administrative hub and 1-8 domestic and/or international Clinical Research Sites with integrated pharmacy and laboratory support. Applications must propose clinical trials and include a Delayed Onset Study record with an anticipated clinical trial designation, because specific protocols are developed during the project period through Network approval. CTUs support the HIV/AIDS Adult Therapeutics, HIV/AIDS Maternal/Adolescent/Pediatric, HIV Prevention, and Immune-Based Prevention networks.
The project period is seven years. Awards are incrementally funded with annual progress and financial reporting. Core funds support infrastructure and administration, and protocol funds are allocated annually based on network needs. Funds must be spent within the approved project period, and no automatic no-cost extensions apply.
Applications undergo scientific merit peer review by a Scientific Review Group, followed by secondary review by an NIH Advisory Council. Funding decisions weigh scientific merit, program relevance, investigator qualifications, institutional capacity, and budget justification. Per-CRS documentation covers staffing, prior IND-level trial experience, quality management, training, IRB processes, pharmacy, laboratory, and data stewardship.
Assistance Listing numbers are 93.8RP and 93.855 (NIAID), 93.HDR (listed for both the Office of AIDS Research and NICHD), 93.HL2 (NHLBI), 93.AGR (NIA), 93.DE1 (NIDCR), 93.KRP (NIDDK), 93.DA1 (NIDA), 93.242 (NIMH), 93.853 (NINDS), and 93.310 (Trans-NIH Research Support).
Synopsis
The purpose of this notice of funding opportunity (NOFO) is to support HIV/AIDS Clinical Trials Network Clinical Trials Units (CTUs). CTUs will provide the infrastructure, as well as the scientific and administrative expertise to conduct clinical studies developed by NIH HIV/AIDS Clinical Trials Networks to advance research in the prevention and treatment of HIV and HIV-associated diseases. CTUs will participate in multiple clinical research studies, accessing relevant populations most heavily impacted by the HIV/AIDS epidemic and studies of highest priority to NIH.
Eligibility
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Files
| File | Type | Posted |
|---|---|---|
| RFA-AI-28-004-Revised-Full-Announcement.html | HTML file | |
| PKG00294603.pdf | ||
| RFA-AI-28-004-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity